A novel series of oxazole incorporated naphthyridine (21a‐j) derivatives were designed and, synthesized followed by screening of their anticancer activity profiles against human breast cancer (MCF‐7), human lung cancer (A549) and human prostate (PC3 & DU‐145) cancer cell lines by employing MTT assay using etoposide as the positive control. Of these compounds, 21a with 3,4,5‐trimethoxy substituent on the aryl moiety attached to oxazole ring showed potent anticancer activity against PC3, A549, MCF‐7, and DU‐145 cell lines with IC50 values of 0.13±0.095 µM; 0.10±0.084 µM; 0.18±0.087 µM and 0.15±0.076 µM respectively. Apart from this, compounds 21b, 21c, and 21d also showed better anticancer activities against four cancer cell lines screened for. These activities were also validated through the molecular docking simulations, which further indicated demonstration of better interaction energy and profile by these compounds.